These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8860280)

  • 41. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening HMO women overdue for both mammograms and pap tests.
    Valanis BG; Glasgow RE; Mullooly J; Vogt TM; Whitlock EP; Boles SM; Smith KS; Kimes TM
    Prev Med; 2002 Jan; 34(1):40-50. PubMed ID: 11749095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survey of population coverage in cervical cancer screening in the Oxford region.
    Coulter A; Baldwin A
    J R Coll Gen Pract; 1987 Oct; 37(303):441-3. PubMed ID: 3505283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Studies on the appropriate frequency of the cervical cancer screening (author's transl)].
    Hando T; Kodama S; Obata N; Goto A; Takeuchi S; Aoki S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1205-8. PubMed ID: 7276648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Smear patterns and spectrum of premalignant and malignant cervical epithelial lesions in postmenopausal Indian women: a hospital-based study.
    Ansari M; Mehdi G; Arif SH; Ansari H; Khan T
    Diagn Cytopathol; 2012 Nov; 40(11):976-83. PubMed ID: 21538964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes from a mass media campaign to promote cervical screening in NSW, Australia.
    Morrell S; Perez DA; Hardy M; Cotter T; Bishop JF
    J Epidemiol Community Health; 2010 Sep; 64(9):777-83. PubMed ID: 19822553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can mobile units improve the strategies for cervical cancer prevention?
    Mauad EC; Nicolau SM; Gomes UA; da Costa Vieira RA; de Castro Mattos JS; Longatto-Filho A; Baracat EC
    Diagn Cytopathol; 2010 Oct; 38(10):727-30. PubMed ID: 20014304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving the effectiveness of cervical cancer screening.
    Ellman R; Chamberlain J
    J R Coll Gen Pract; 1984 Oct; 34(267):537-42. PubMed ID: 6492026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How reminders given to patients and physicians affected pap smear use in a health maintenance organization: results of a randomized controlled trial.
    Burack RC; Gimotty PA; George J; McBride S; Moncrease A; Simon MS; Dews P; Coombs J
    Cancer; 1998 Jun; 82(12):2391-400. PubMed ID: 9635532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The vicious cycle of inadequate early detection: a complementary study on barriers to cervical cancer screening among middle-aged and older women.
    Leach CR; Schoenberg NE
    Prev Chronic Dis; 2007 Oct; 4(4):A95. PubMed ID: 17875270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing the uptake of cervical smears: strategies implemented among general practitioners in Auckland.
    White GE; McAvoy BR; Gleisner S
    N Z Med J; 1993 Aug; 106(962):357-60. PubMed ID: 8255562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patients with cervical cancer: why did screening not prevent these cases?
    de Bie RP; Vergers-Spooren HC; Massuger LF; Siebers AG; Salet-van der Pol MR; Vedder JE; Melchers WJ; Bulten J; Bekkers RL
    Am J Obstet Gynecol; 2011 Jul; 205(1):64.e1-7. PubMed ID: 21481838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barriers to mammography and Pap smear screening among women who recently had neither, one or both types of screening.
    Glasgow RE; Whitlock EP; Valanis BG; Vogt TM
    Ann Behav Med; 2000; 22(3):223-8. PubMed ID: 11126467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Race and ethnic disparities in cervical cancer screening in a safety-net system.
    Owusu GA; Eve SB; Cready CM; Koelln K; Trevino F; Urrutia-Rojas X; Baumer J
    Matern Child Health J; 2005 Sep; 9(3):285-95. PubMed ID: 16163439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of area HMO market share on cancer screening.
    Baker LC; Phillips KA; Haas JS; Liang SY; Sonneborn D
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1751-72. PubMed ID: 15533185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gynecological care of elderly women. Another look at Papanicolaou smear testing.
    Mandelblatt J; Gopaul I; Wistreich M
    JAMA; 1986 Jul; 256(3):367-71. PubMed ID: 3723723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Survey of screening for uterine cervical cancer in Wakayama city (author's transl)].
    Yokota H; Mabuchi Y; Hosomichi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec; 33(12):2072-8. PubMed ID: 7338660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of cervical cancer screening rates among women with traumatic spinal cord injury and the general population.
    Guilcher SJ; Newman A; Jaglal SB
    J Womens Health (Larchmt); 2010 Jan; 19(1):57-63. PubMed ID: 20088659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Older Hispanic women, health literacy, and cervical cancer screening.
    Flores BE; Acton GJ
    Clin Nurs Res; 2013 Nov; 22(4):402-15. PubMed ID: 23729023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pap tests--what do women expect?
    Stewart R; Thistlethwaite J
    Aust Fam Physician; 2010 Oct; 39(10):775-8. PubMed ID: 20890481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.